OMX Stockholm Pharmaceuticals a SX201030GI 指数
7749.85 SEK
{{ price }}
0.901218%
{{change_pct}}%
OMX Stockholm Pharmaceuticals a 价格走势图
过去24小时内的前5名涨幅最大者
| SANION.ST | Saniona AB (publ) | +2.77% | |
|---|---|---|---|
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | +2.72% | |
| VIVE.ST | Vivesto AB | +1.98% | |
| ACTI.ST | Active Biotech AB (publ) | +1.24% | |
| VICO.ST | Vicore Pharma Holding AB (publ) | +1.1% |
过去24小时内的前5名跌幅最大者
| CANTA.ST | Cantargia AB (publ) | -8.12% | |
|---|---|---|---|
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | -5.12% | |
| ATORX.ST | Alligator Bioscience AB (publ) | -4.29% | |
| ACE.ST | Ascelia Pharma AB (publ) | -4.05% | |
| MVIR.ST | Medivir AB (publ) | -3.38% |
OMX Stockholm Pharmaceuticals a SX201030GI 财务与交易概览
| OMX Stockholm Pharmaceuticals a指数价格 | 7749.85 SEK |
| 昨日收盘价 | N/A |
| 开盘价 | N/A |
| 买入价 | N/A x N/A |
| 卖出价 | N/A x N/A |
| 当日价格范围 | N/A |
| 52 周价格范围 | N/A |
| 成交量 | N/A |
| 平均成交量 | N/A |
交易信息
OMX Stockholm Pharmaceuticals a 指数价格历史
| 52 周最高 | N/A |
| 52 周最低 | N/A |
| 50 天移动平均线 | N/A |
| 200 天移动平均线 | N/A |
SX201030GI Index Statistics
| 平均成交量（3 个月） | N/A |
| 平均每日成交量（10 天） | N/A |
OMX Stockholm Pharmaceuticals a指数问答
什么是当前的SX201030GI指数价格？
OMX Stockholm Pharmaceuticals a SX201030GI指数今天的价格是7749.85 SEK。
如何购买OMX Stockholm Pharmaceuticals a指数？
您可以在Tech Market交易所购买SX201030GI指数。请联系您的财务顾问以选择经纪商。
OMX Stockholm Pharmaceuticals a指数的股票代码是什么？
OMX Stockholm Pharmaceuticals a指数的股票代码是SX201030GI。
OMX Stockholm Pharmaceuticals a指数包含多少个成分？
OMX Stockholm Pharmaceuticals a指数包含32个成分。
OMX Stockholm Pharmaceuticals a指数属于哪个国家？
OMX Stockholm Pharmaceuticals a指数所属国家是United States。
OMX Stockholm Pharmaceuticals a指数属于哪个交易所？
OMX Stockholm Pharmaceuticals a指数所属交易所是Tech Market。
OMX Stockholm Pharmaceuticals a 成分
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Swedish Orphan Biovitrum AB (publ) SOBI.ST | $332.4 32.45 USD |
+2.72
|
$116.31B 11.35B USD | $339.96K 33.18K USD | $324.8 31.7 USD | $334 32.6 USD | $116.31B 11.35B USD | 0 | $0 0 USD |
| Camurus AB (publ) CAMX.ST | $611 59.64 USD |
-2.55
|
$36.42B 3.56B USD | $116.98K 11.42K USD | $607 59.25 USD | $626 61.11 USD | $36.42B 3.56B USD | 50.74 | $12.04 1.18 USD |
| BioArctic AB (publ) BIOA-B.ST | $284.2 27.74 USD |
+0.71
|
$26.14B 2.55B USD | $120.03K 11.72K USD | $278.8 27.21 USD | $286 27.92 USD | $26.14B 2.55B USD | 23.58 | $12.05 1.18 USD |
| BioGaia AB (publ) BIOG-B.ST | $100.9 9.85 USD |
+0.3
|
$10.2B 995.37M USD | $305.71K 29.84K USD | $99.3 9.69 USD | $100.9 9.85 USD | $10.2B 995.37M USD | 32.33 | $3.12 0.3 USD |
| MedCap AB (publ) MCAP.ST | $581 56.71 USD |
-1.86
|
$8.95B 873.89M USD | $17.11K 1.67K USD | $577 56.32 USD | $589 57.49 USD | $8.95B 873.89M USD | 44.01 | $13.2 1.29 USD |
| Hansa Biopharma AB (publ) HNSA.ST | $30.4 2.97 USD |
-1.94
|
$3.03B 295.93M USD | $506.24K 49.41K USD | $30 2.93 USD | $30.7 3 USD | $3.03B 295.93M USD | 0 | -$9.08 -0.8 USD |
| Vicore Pharma Holding AB (publ) VICO.ST | $11 1.07 USD |
+1.1
|
$2.69B 262.56M USD | $352.98K 34.45K USD | $10.86 1.06 USD | $11.14 1.09 USD | $2.69B 262.56M USD | 0 | -$1.98 -0.1 USD |
| Egetis Therapeutics AB (publ) EGTX.ST | $6.31 0.62 USD |
+0.96
|
$2.65B 258.91M USD | $755.57K 73.75K USD | $6.1 0.6 USD | $6.37 0.62 USD | $2.65B 258.91M USD | 0 | -$1 -0.09 USD |
| Saniona AB (publ) SANION.ST | $16.3 1.59 USD |
+2.77
|
$2.25B 219.62M USD | $1.28M 125.22K USD | $15.82 1.54 USD | $16.48 1.61 USD | $2.25B 219.62M USD | 8.19 | $1.99 0.19 USD |
| BioInvent International AB (publ) BINV.ST | $33.15 3.24 USD |
-2.21
|
$2.18B 212.93M USD | $149.99K 14.64K USD | $33.1 3.23 USD | $34.85 3.4 USD | $2.18B 212.93M USD | 0 | -$4.93 -0.4 USD |
| Oncopeptides AB (publ) ONCO.ST | $5.79 0.57 USD |
+0.7
|
$1.57B 153.25M USD | $2.12M 206.84K USD | $5.7 0.56 USD | $5.91 0.58 USD | $1.57B 153.25M USD | 0 | -$1.06 -0.1 USD |
| SynAct Pharma AB SYNACT.ST | $22.9 2.24 USD |
-2.14
|
$1.26B 123.29M USD | $134.18K 13.1K USD | $22.6 2.21 USD | $24.2 2.36 USD | $1.26B 123.29M USD | 0 | -$2.18 -0.2 USD |
| Xspray Pharma AB (publ) XSPRAY.ST | $24.9 2.43 USD |
-1.58
|
$1.06B 103.06M USD | $89.33K 8.72K USD | $24.9 2.43 USD | $25.5 2.49 USD | $1.06B 103.06M USD | 0 | -$7.05 -0.6 USD |
| Orexo AB (publ) ORX.ST | $27 2.64 USD |
-1.64
|
$948.99M 92.63M USD | $66.86K 6.53K USD | $25.95 2.53 USD | $27.75 2.71 USD | $948.99M 92.63M USD | 0 | -$5.85 -0.5 USD |
| Cantargia AB (publ) CANTA.ST | $3.28 0.32 USD |
-8.12
|
$815.45M 79.6M USD | $5.05M 493.09K USD | $3.21 0.31 USD | $3.55 0.35 USD | $815.45M 79.6M USD | 0 | -$0.79 -0.07 USD |
| Infant Bacterial Therapeutics AB (publ) IBT-B.ST | $58.1 5.67 USD |
-3.01
|
$770.93M 75.25M USD | $3.77K 367.61 USD | $58.1 5.67 USD | $60.2 5.88 USD | $770.93M 75.25M USD | 0 | -$7.6 -0.7 USD |
| Ascelia Pharma AB (publ) ACE.ST | $3.08 0.3 USD |
-4.05
|
$390.59M 38.13M USD | $1.34M 130.42K USD | $3.06 0.3 USD | $3.21 0.31 USD | $390.59M 38.13M USD | 0 | -$1.02 -0.09 USD |
| Mendus AB (publ) IMMU.ST | $7.4 0.72 USD |
+0.14
|
$389.6M 38.03M USD | $39.82K 3.89K USD | $6.91 0.67 USD | $7.4 0.72 USD | $389.6M 38.03M USD | 0 | -$2.11 -0.2 USD |
| Moberg Pharma AB (publ) MOB.ST | $7.79 0.76 USD |
-1.39
|
$366.13M 35.74M USD | $93.65K 9.14K USD | $7.53 0.74 USD | $7.99 0.78 USD | $366.13M 35.74M USD | 0 | -$6.6 -0.6 USD |
| Karolinska Development AB (publ) KDEV.ST | $0.8599 0.08 USD |
-1.04
|
$233.66M 22.81M USD | $283.41K 27.66K USD | $0.8499 0.08 USD | $0.88 0.09 USD | $233.66M 22.81M USD | 0 | -$0.29 -0.02 USD |
- {{ link.label }} {{link}}